PRE 14A

PRE 14A

Company: REVIVA PHARMACEUTICALS HOLDINGS, INC.
Filed: April 21, 2020
Period of Report: April 21, 2020
Accession Number: 0001104659-20-049026

View Document ↗ View on SEC.gov ↗